Keyphrases
Peru
100%
Tuberculosis
52%
Lima
48%
AIDS/HIV
31%
Antiretroviral Therapy
29%
Pulmonary Tuberculosis
28%
Multidrug-resistant Tuberculosis (MDR-TB)
27%
Drug Susceptibility Testing
24%
HIV Patients
22%
Peruvian
22%
Tuberculosis Transmission
20%
Microscopic Observation Drug Susceptibility
17%
Latent Tuberculosis Infection
16%
Mycobacterium Tuberculosis (M. tb)
16%
Cough Frequency
15%
Cough
14%
Infectiousness
13%
Drug Resistance
12%
HIV Infection
11%
First-line Antiretroviral Therapy
11%
Tuberculosis Treatment
11%
Infection Control
11%
HIV Drug Resistance
10%
Health Personnel
10%
Influenza Vaccine Effectiveness
10%
Erucism
10%
Lonomia
10%
Tuberculous Meningitis
10%
Tuberculosis Disease
10%
Quantitative PCR
9%
Guinea pig
9%
HIV-positive
9%
Tuberculosis Diagnosis
8%
Emergency Department
8%
Tuberculosis Patients
8%
Antiretroviral
8%
Toxoplasma Gondii (T. gondii)
7%
Cryptosporidium
7%
Virological Failure
7%
Clinical Manifestations
7%
Cryptosporidium Infection
7%
Caterpillar
7%
Sputum
7%
Air Sampling
7%
Cardiovascular Disease
7%
Human Immunodeficiency Virus Type 1 (HIV-1)
7%
HIV-negative Patients
6%
Broth Culture
6%
Lymphadenopathy
6%
Resource-poor Settings
6%
Tuberculosis Infection
6%
Acute Myocardial Infarction
6%
Tuberculosis Mortality
6%
Human Immunodeficiency Virus Infection
6%
Influenza Virus
5%
Airborne Transmission
5%
Sampling Model
5%
Infection Control Measures
5%
Polymerase Chain Reaction Assay
5%
Hospitalized Patients
5%
Diagnostic Test
5%
Blood Specimen
5%
Tuberculosis Infection Control
5%
Prospective Cohort Study
5%
Inflammatory Biomarkers
5%
Virion
5%
Broth
5%
Confidence Interval
5%
Microscopy
5%
Chikungunya Virus (CHIKV)
5%
Rest of the World
5%
Meningoencephalitis
5%
Cryptococcus Gattii
5%
Hydrogel Nanoparticles
5%
Herpes Simplex Virus Infection
5%
Herpes Simplex Virus Encephalitis
5%
Hospital Emergency Department
5%
Multicenter Prospective Study
5%
Risk Control
5%
Felis
5%
First Day
5%
GeneXpert
5%
Tuberculosis Meningitis
5%
Toxoplasmic Encephalitis
5%
Klebsiella Pneumoniae (K. pneumoniae)
5%
New Delhi
5%
β-lactamase
5%
Geriatric Patients
5%
Ascaris Lumbricoides
5%
First Case Report
5%
Vibrio Cholerae
5%
H1N1
5%
Influenza A H1N1
5%
O139
5%
Literatur
5%
Cirrhotic Patients
5%
Non-O1/non-O139 Vibrio Cholerae
5%
Intestinal Obstruction
5%
Histological Examination
5%
Bellis
5%
Medicine and Dentistry
Human Immunodeficiency Virus
63%
Tuberculosis
28%
Drug Sensitivity
27%
Multidrug Resistant Tuberculosis
22%
Disease
22%
Coughing
20%
Antiretroviral Therapy
20%
Lung Tuberculosis
17%
Drug Resistance
17%
Latent Tuberculosis
16%
Symptom
14%
Infection Control
13%
Mycobacterium Tuberculosis
13%
Laboratory Test
11%
Influenza Virus
11%
Infection
11%
Medical History
10%
Body Surface
10%
Hemolytic Anemia
10%
Coagulopathy
10%
Aortic Aneurysm Endovascular Graft
10%
Bleeding Disorder
10%
Influenza Vaccine
10%
Human Immunodeficiency Virus Infection
9%
Emergency Department
9%
Sputum
9%
Mixed Infection
8%
Diarrhea
8%
Tuberculosis Treatment
8%
Real-Time Polymerase Chain Reaction
7%
Diagnosis
7%
Air Sampling
7%
Airborne Infection
7%
Arm
6%
Placebo
6%
Public Health
6%
Acute Heart Infarction
6%
Silo-Filler's Disease
6%
Influenza Vaccination
6%
Lymphadenopathy
6%
Cardiovascular Disease
6%
HIV/AIDS
5%
Diagnostic Test
5%
Mantoux Test
5%
Health Care Cost
5%
Chikungunya
5%
Respiratory Tract Infection
5%
Epidemic
5%
Tuberculous Meningitis
5%
Linear Regression Analysis
5%
Pediatrics Patient
5%
HIV Drug Resistance
5%
Geriatrics
5%
Chronic Diarrhea
5%
Ascariasis
5%
Bowel Obstruction
5%
Encephalitis
5%
Radiography
5%
Computer Assisted Diagnosis
5%
Cluster Randomized Trial
5%
Pediatrics
5%
Nanoparticle
5%
Cryptococcal Meningitis
5%
Adjuvant Therapy
5%
Recombinant Interferon
5%
Vertical Transmission
5%
Gamma Interferon
5%
Prospective Cohort Study
5%
Dolutegravir
5%
Prophylaxis
5%
Delamanid
5%
HIV Resistance
5%
Highly Active Antiretroviral Therapy
5%
Isoniazid
5%
Hemophagocytic Syndrome
5%
Histoplasmosis
5%
Meningitis
5%
Influenza A Virus (H1N1)
5%
Toxoplasma gondii
5%
Blood Clot
5%
Tuberculous Lymphadenitis
5%